115 related articles for article (PubMed ID: 37977033)
1. SCGN and STAT3 expressions are associated with the prognosis of ccRCC.
Lai C; Gong J; Tang J; Liu Q; Zhang M; Lai M; Zhang D; Teng X
Pathol Res Pract; 2023 Dec; 252():154940. PubMed ID: 37977033
[TBL] [Abstract][Full Text] [Related]
2. Nuclear and cytosolic pS727-STAT3 levels correlate with overall survival of patients affected by clear cell renal cell carcinoma (ccRCC).
Arévalo J; Lorente D; Trilla E; Salcedo MT; Morote J; Meseguer A
Sci Rep; 2021 Mar; 11(1):6957. PubMed ID: 33772065
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
4. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma.
Campagna R; Cecati M; Pozzi V; Fumarola S; Pompei V; Milanese G; Galosi AB; Sartini D; Emanuelli M
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):51-55. PubMed ID: 29974846
[TBL] [Abstract][Full Text] [Related]
5. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
[TBL] [Abstract][Full Text] [Related]
6. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
7. The correlation between low vitamin D status and renal interleukin-6/STAT3 hyper-activation in patients with clear cell renal cell carcinoma.
Song J; Xu S; Zhang ZH; Chen YH; Gao L; Xie DD; Sun GP; Yu DX; Xu DX
Steroids; 2019 Oct; 150():108445. PubMed ID: 31295461
[TBL] [Abstract][Full Text] [Related]
8. ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3.
Li YL; Wu LW; Zeng LH; Zhang ZY; Wang W; Zhang C; Lin NM
Oncogene; 2020 Sep; 39(39):6203-6217. PubMed ID: 32826950
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
11. Higher TYROBP and lower SOX6 as predictive biomarkers for poor prognosis of clear cell renal cell carcinoma: A pilot study.
Lv XQ; Zhang KB; Guo X; Pei L; Li F
Medicine (Baltimore); 2022 Dec; 101(51):e30658. PubMed ID: 36595751
[TBL] [Abstract][Full Text] [Related]
12. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
[TBL] [Abstract][Full Text] [Related]
13. A Study on the Immunohistochemical Expressions of Leptin and Leptin Receptor in Clear Cell Renal Cell Carcinoma.
Perumal K; Mun KS; Yap NY; Razack AHA; Gobe GC; Ong TA; Kuppusamy S; Rajandram R
Biomed Res Int; 2020; 2020():3682086. PubMed ID: 32802842
[TBL] [Abstract][Full Text] [Related]
14. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma.
Liu Q; Zhang X; Tang H; Liu J; Fu C; Sun M; Zhao L; Wei M; Yu Z; Wang P
Pathol Oncol Res; 2020 Jul; 26(3):1583-1594. PubMed ID: 31489573
[TBL] [Abstract][Full Text] [Related]
16. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
[TBL] [Abstract][Full Text] [Related]
17. TTC13 expression and STAT3 activation may form a positive feedback loop to promote ccRCC progression.
Xie L; Fang Y; Chen J; Meng W; Guan Y; Gong W
PeerJ; 2023; 11():e16316. PubMed ID: 37927783
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma.
Yuan Y; Yang X; Li Y; Liu Q; Wu F; Qu H; Gao H; Ge J; Xu Y; Wang H; Wang Y; Zhao Z
Pathol Res Pract; 2020 Nov; 216(11):153227. PubMed ID: 33027752
[TBL] [Abstract][Full Text] [Related]
19. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients.
Fabbri L; Dufies M; Lacas-Gervais S; Gardie B; Gad-Lapiteau S; Parola J; Nottet N; Meyenberg Cunha de Padua M; Contenti J; Borchiellini D; Ferrero JM; Leclercq NR; Ambrosetti D; Mograbi B; Richard S; Viotti J; Chamorey E; Sadaghianloo N; Rouleau M; Craigen WJ; Mari B; Clavel S; Pagès G; Pouysségur J; Bost F; Mazure NM
Theranostics; 2020; 10(6):2696-2713. PubMed ID: 32194829
[No Abstract] [Full Text] [Related]
[Next] [New Search]